Abstract
Background
Recurrent pregnancy loss is defined as having the experience of three or more repeated pregnancy losses. Despite numerous studies, RPL etiology remains unclear; in this respect, many etiological factors have been thoroughly investigated. However, the contribution of male factors in RPL at the sperm aneuploidy has rarely been examined. The aim of the current study is to assess the existence of autosome and sex chromosome aneuploidy in sperm of men with history of recurrent pregnancy loss. In this prospective study, 50 men with a history of recurrent pregnancy loss were included as case group and 15 men with normal sperm analysis, without abortion history and with at least one child were included as control group. Two- and three-color fluorescence in situ hybridization technique was used for screening aneuploidy in 13, 18, 21, X, and Y chromosomes.
Results
Overall, the comparison of sperm aneuploidies in sex and autosome chromosomes (13, 21, 18) between case and control groups showed that chromosomal abnormality was significantly increased in men with RPL than men without history of RPL. Among all examined cells, about 18.28% nullisomy, 6.48% disomy, and 0.06% trisomy were observed. As well, two cells with XXYY and one cell with XXXY karyotype were observed. Among the analyzed chromosomes, the prevalence of nullisomy of chromosome 13 was higher than other studied chromosomes.
Conclusion
The results suggest the implication of sperm chromosomal abnormalities in recurrent pregnancy loss. Clinical application of FISH-based screening test is recommended for investigating sperm aneuploidy in RPL cases to counsel couples for making informed decision.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Dehghani Ashkezari, Mahmood 4 ; Pourfahraji Fakhrabadi, Majid 3 ; Sabbagh Nejad Yazd, Samira 3 1 Shahid Sadoughi University of Medical Sciences, Abortion Research Center, Yazd Institute of Reproductive Sciences, Yazd, Iran (GRID:grid.412505.7) (ISNI:0000 0004 0612 5912); Islamic Azad University, Medical Biotechnology Research Center, Ashkezar Branch, Yazd, Iran (GRID:grid.466829.7)
2 Shahid Sadoughi University of Medical Sciences, Yazd Institute of Reproductive Sciences, Yazd, Iran (GRID:grid.412505.7) (ISNI:0000 0004 0612 5912)
3 Shahid Sadoughi University of Medical Sciences, Abortion Research Center, Yazd Institute of Reproductive Sciences, Yazd, Iran (GRID:grid.412505.7) (ISNI:0000 0004 0612 5912)
4 Islamic Azad University, Medical Biotechnology Research Center, Ashkezar Branch, Yazd, Iran (GRID:grid.466829.7)





